Back to results
US 8,008,258 B2Granted
Cop 1 for treatment of inflammatory bowel diseases
AssigneeYeda Research and Development Co. Ltd.
InventorsRina Aharoni, Ruth Arnon, Basak Kayhan
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of Copolymer 1 (glatiramer acetate), a Copolymer 1-related polypeptide, or a Copolymer 1-related peptide, for the treatment of inflammatory bowel diseases such as Crohn's disease and ulcerative colitis.
Claims22
A method for inhibiting weight loss, inducing weight regain or reducing macroscopic colonic damage in a patient suffering from severe Crohn's disease, comprising administering to said patient by daily injection an amount of an active agent selected from the group consisting of
- i) Copolymer 1 and Copolymer 1-related peptides consisting of random three- or four-amino acid copolymers made up of one amino acid selected from three or four of the following groups:
- (a) lysine and arginine;
- (b) glutamic acid and aspartic acid;
- (c) alanine and glycine;
- and
- (d) tyrosine and tryptophan;
- and
- ii) a Copolymer 1-related peptide having the sequence of any of SEQ ID NOs:
- 1-32,
- in an amount effective for inhibiting weight loss, inducing weight regain or reducing macroscopic colonic damage in the patient.
7 more elements
Dependencies are inferred from the claim text.